trending Market Intelligence /marketintelligence/en/news-insights/trending/tzjytzlljhooi4cvez7ybg2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

DiaMedica Therapeutics appoints chief medical officer

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


DiaMedica Therapeutics appoints chief medical officer

Minneapolis-based biotechnology company DiaMedica Therapeutics Inc. appointed Harry Alcorn Jr. as chief medical officer.

Alcorn previously served as chief scientific officer at DaVita Clinical Research. He has also served on the boards of the Association of Clinical Pharmacology Units and MEDTOX Laboratories Inc.

DiaMedica develops treatments for neurological and kidney diseases.